AtaiBeckley ATAI
NASDAQ ATAI
$7.36 +0.01 (+0.20%)
As of: Sep 4, 2026 · 2:30 PM EDT

AtaiBeckley (ATAI) Equity Income (2020 - 2024)

Analysis

AtaiBeckley (ATAI) Equity Income (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.41 Bn 27.57 Bn - 4.08 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -
10 AtaiBeckley 1.60 Bn 1.60 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -26,000.00
Jun 30, 2024 -273,000.00
Mar 31, 2024 -1.70 Mn
Dec 31, 2023 -394,000.00
Sep 30, 2023 -238,000.00
Jun 30, 2023 -1.93 Mn
Mar 31, 2023 -1.03 Mn
Dec 31, 2022 -1.33 Mn
Sep 30, 2022 -2.43 Mn
Jun 30, 2022 -6.65 Mn
Mar 31, 2022 -5.60 Mn
Dec 31, 2021 -49.12 Mn
Sep 30, 2021 -4.80 Mn
Jun 30, 2021 -2.94 Mn
Mar 31, 2021 -1.70 Mn
Dec 31, 2020 -2.81 Mn
Sep 30, 2020 -61.86 Mn
Jun 30, 2020 -9.81 Mn